We are live on ! Find out more
CT

Cambridge Trust Portfolio holdings

AUM $2.64B
1-Year Est. Return 28.73%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.45B
AUM Growth
+$339M
Cap. Flow
+$259M
Cap. Flow %
10.57%
Top 10 Hldgs %
27.26%
Holding
275
New
45
Increased
102
Reduced
97
Closed
9

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$23.2M
2
BABA icon
Alibaba
BABA
+$21.9M
3
VZ icon
Verizon
VZ
+$12.1M
4
NEE icon
NextEra Energy
NEE
+$11.5M
5
META icon
Meta Platforms (Facebook)
META
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 18.93%
2 Financials 17.8%
3 Miscellaneous 16.26%
4 Healthcare 10.14%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
76
Novartis
NVS
$292B
$9.22M 0.38%
107,901
+2,019
+2% +$181K
XOM icon
77
ExxonMobil
XOM
$644B
$9.02M 0.37%
161,623
+83,536
+107% +$4.38M
CATC
78
DELISTED
CAMBRIDGE BANCORP
CATC
$8.68M 0.35%
102,931
-3,400
-3% -$266K
ABT icon
79
Abbott
ABT
$195B
$8.58M 0.35%
71,561
+4,205
+6% +$498K
TXN icon
80
Texas Instruments
TXN
$236B
$7.55M 0.31%
39,945
+31,527
+375% +$5.48M
CTXS
81
DELISTED
Citrix Systems Inc
CTXS
$7.04M 0.29%
50,136
+29
+0.1% +$3.89K
EEM icon
82
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$6.33M 0.26%
118,732
-4,719
-4% -$258K
PEP icon
83
PepsiCo
PEP
$193B
$5.85M 0.24%
41,377
+2,161
+6% +$297K
CBT icon
84
Cabot Corp
CBT
$4.32B
$5.54M 0.23%
105,663
VIG icon
85
Vanguard Dividend Appreciation ETF
VIG
$113B
$5.49M 0.22%
37,314
+34,851
+1,415% +$4.96M
DLR icon
86
Digital Realty Trust
DLR
$68.8B
$5.39M 0.22%
38,298
+2,749
+8% +$380K
CLX icon
87
Clorox
CLX
$12.4B
$5.26M 0.21%
27,267
-785
-3% -$151K
ATO icon
88
Atmos Energy
ATO
$28.2B
$5.04M 0.21%
50,935
-220
-0.4% -$20K
A icon
89
Agilent Technologies
A
$43.4B
$4.88M 0.2%
38,346
+1,665
+5% +$206K
BRK.B icon
90
Berkshire Hathaway Class B
BRK.B
$1.08T
$4.75M 0.19%
18,600
+2,077
+13% +$504K
T icon
91
AT&T
T
$178B
$4.67M 0.19%
204,485
-101,976
-33% -$2.25M
AMD icon
92
Advanced Micro Devices
AMD
$760B
$4.54M 0.19%
57,790
-63
-0.1% -$5.42K
INTC icon
93
Intel
INTC
$473B
$4.3M 0.18%
67,214
+6,866
+11% +$409K
WST icon
94
West Pharmaceutical
WST
$23.7B
$4.28M 0.17%
15,200
-116
-0.8% -$33.2K
ABBV icon
95
AbbVie
ABBV
$451B
$4.05M 0.17%
37,449
+3,665
+11% +$392K
MMM icon
96
3M
MMM
$89.9B
$3.39M 0.14%
21,066
+562
+3% +$84.1K
PFE icon
97
Pfizer
PFE
$159B
$3.37M 0.14%
93,087
+8,608
+10% +$306K
CCMP
98
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$3.2M 0.13%
18,124
CSCO icon
99
Cisco
CSCO
$433B
$3.16M 0.13%
61,169
+3,786
+7% +$178K
ESGU icon
100
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
$2.63M 0.11%
+28,965
New +$2.57M

Similar funds

Cambridge Trust's Q1 2021 Portfolio in Review

As of Q1 2021, Cambridge Trust held 275 positions worth $2.45B, up 16% from $2.11B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Cambridge Trust deployed $259M of net new capital in Q1 2021, opening 45 new positions and adding to 102 existing holdings. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 264,440 shares worth $29.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Financials and Miscellaneous.

On the sell side, the largest reduction was Merck, an estimated $23.2M trimmed.

  • Cambridge Trust's largest Q1 2021 buy was iShares 7-10 Year Treasury Bond ETF: 264,440 shares worth $29.9M.
  • Cambridge Trust added most to iShares Core S&P 500 ETF in Q1 2021, an estimated $39.6M increase.
  • Cambridge Trust's biggest Q1 2021 reduction was Merck, cutting an estimated $23.2M.
  • Cambridge Trust fully exited Alibaba in Q1 2021, selling an estimated $21.9M.
  • Cambridge Trust's ten largest holdings make up 27% of its $2.45B portfolio in Q1 2021.
  • Cambridge Trust opened 45 new positions and closed 9 in Q1 2021.
  • Cambridge Trust's portfolio value rose 16% quarter-over-quarter to $2.45B.

Based on Cambridge Trust's 13F filing for Q1 2021, filed 14 May 2021.